{"id":"https://openalex.org/W2963845741","doi":"https://doi.org/10.3897/pharmacia.66.e35976","title":"4-aminopyridine \u2013 the new old drug for the treatment of neurodegenerative diseases","display_name":"4-aminopyridine \u2013 the new old drug for the treatment of neurodegenerative diseases","publication_year":2019,"publication_date":"2019-07-22","ids":{"openalex":"https://openalex.org/W2963845741","doi":"https://doi.org/10.3897/pharmacia.66.e35976","mag":"2963845741"},"language":"en","primary_location":{"id":"doi:10.3897/pharmacia.66.e35976","doi":"https://doi.org/10.3897/pharmacia.66.e35976","is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.66.e35976","pdf_url":"https://pharmacia.pensoft.net/article/35976/download/pdf/","source":{"id":"https://openalex.org/S4210231629","display_name":"Pharmacia","issn_l":"0428-0296","issn":["0428-0296","2603-557X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacia","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2963845741"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://pharmacia.pensoft.net/article/35976/download/pdf/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5084439161","display_name":"Ivanka Kostadinova","orcid":"https://orcid.org/0000-0002-7283-8983","observed_orcids":["https://orcid.org/0000-0002-7283-8983"]},"institutions":[{"id":"https://openalex.org/I30147112","display_name":"Medical University of Sofia","ror":"https://ror.org/01n9zy652","country_code":"BG","type":"education","lineage":["https://openalex.org/I30147112"]}],"countries":["BG"],"is_corresponding":false,"raw_author_name":"Ivanka Kostadinova","raw_affiliation_strings":["Department of Pharmacology, Pharmacotherapy and Toxicology , Faculty of Pharmacy , Medical University , 2 nd Dunav Str. , Sofia 1000 , Bulgaria","Medical University"],"raw_orcid":"https://orcid.org/0000-0002-7283-8983","affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Pharmacotherapy and Toxicology , Faculty of Pharmacy , Medical University , 2 nd Dunav Str. , Sofia 1000 , Bulgaria","institution_ids":["https://openalex.org/I30147112"]},{"raw_affiliation_string":"Medical University","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112410511","display_name":"Nikolai D. Danchev","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I30147112","display_name":"Medical University of Sofia","ror":"https://ror.org/01n9zy652","country_code":"BG","type":"education","lineage":["https://openalex.org/I30147112"]}],"countries":["BG"],"is_corresponding":false,"raw_author_name":"Nikolai Danchev","raw_affiliation_strings":["Department of Pharmacology, Pharmacotherapy and Toxicology , Faculty of Pharmacy , Medical University , 2 nd Dunav Str. , Sofia 1000 , Bulgaria","Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Pharmacotherapy and Toxicology , Faculty of Pharmacy , Medical University , 2 nd Dunav Str. , Sofia 1000 , Bulgaria","institution_ids":["https://openalex.org/I30147112"]},{"raw_affiliation_string":"Medical University","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I30147112"],"apc_list":{"value":100,"currency":"EUR","value_usd":107},"apc_paid":{"value":100,"currency":"EUR","value_usd":107},"fwci":1.8333,"has_fulltext":true,"cited_by_count":24,"citation_normalized_percentile":{"value":0.8430556,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"66","issue":"2","first_page":"67","last_page":"74"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.6890000104904175,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.6890000104904175,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.21629999577999115,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.02410000003874302,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/4-aminopyridine","display_name":"4-aminopyridine","score":1.0},{"id":"https://openalex.org/keywords/potassium-channel-blockers","display_name":"potassium channel blockers","score":0.9070000052452087},{"id":"https://openalex.org/keywords/neurodegenerative-diseases","display_name":"neurodegenerative diseases","score":0.9909999966621399},{"id":"https://openalex.org/keywords/multiple-sclerosis","display_name":"multiple sclerosis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/demyelination","display_name":"demyelination","score":0.8190000057220459},{"id":"https://openalex.org/keywords/neuromuscular-blockade-reversal","display_name":"neuromuscular blockade reversal","score":0.8169999718666077},{"id":"https://openalex.org/keywords/walking-disability","display_name":"walking disability","score":0.5910000205039978},{"id":"https://openalex.org/keywords/nerve-conduction","display_name":"nerve conduction","score":0.8029999732971191},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.6129999756813049}],"concepts":[{"id":"https://openalex.org/C2780922449","wikidata":"https://www.wikidata.org/wiki/Q372539","display_name":"4-Aminopyridine","level":3,"score":0.9851057529449463},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6686998605728149},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6553176641464233},{"id":"https://openalex.org/C2778457506","wikidata":"https://www.wikidata.org/wiki/Q7234689","display_name":"Potassium channel blocker","level":3,"score":0.644190788269043},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4771099388599396},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4742414355278015},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.45482754707336426},{"id":"https://openalex.org/C2778087735","wikidata":"https://www.wikidata.org/wiki/Q2393470","display_name":"2-Aminopyridine","level":2,"score":0.4394893944263458},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3471001982688904},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3200535774230957},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.2660757899284363},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.19026488065719604},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.10823172330856323},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.10012272000312805},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.3897/pharmacia.66.e35976","doi":"https://doi.org/10.3897/pharmacia.66.e35976","is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.66.e35976","pdf_url":"https://pharmacia.pensoft.net/article/35976/download/pdf/","source":{"id":"https://openalex.org/S4210231629","display_name":"Pharmacia","issn_l":"0428-0296","issn":["0428-0296","2603-557X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacia","raw_type":"journal-article"},{"id":"pmh:10.3897/pharmacia.66.e35976","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.66.e35976","pdf_url":null,"source":{"id":"https://openalex.org/S199213172","display_name":"ZooKeys","issn_l":"1313-2970","issn":["1313-2970","1313-2989"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-d","jufo-1","norway-1","oarl","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacia 66(2): 67-74","raw_type":"Research Article"},{"id":"pmh:oai:doaj.org/article:af97cda93e514a85b96ab24a5ec07359","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/af97cda93e514a85b96ab24a5ec07359","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacia, Vol 66, Iss 2, Pp 67-74 (2019)","raw_type":"article"},{"id":"pmh:oai:zenodo.org:3355849","doi":null,"is_oa":true,"landing_page_url":"https://zenodo.org/record/3355849","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacia 66((2)) 67-74","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3897/pharmacia.66.e35976","doi":"https://doi.org/10.3897/pharmacia.66.e35976","is_oa":true,"landing_page_url":"https://doi.org/10.3897/pharmacia.66.e35976","pdf_url":"https://pharmacia.pensoft.net/article/35976/download/pdf/","source":{"id":"https://openalex.org/S4210231629","display_name":"Pharmacia","issn_l":"0428-0296","issn":["0428-0296","2603-557X"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321056","host_organization_name":"Pensoft Publishers","host_organization_lineage":["https://openalex.org/P4310321056"],"host_organization_lineage_names":["Pensoft Publishers"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacia","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9476000070571899,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2963845741.pdf","grobid_xml":"https://content.openalex.org/works/W2963845741.grobid-xml"},"referenced_works_count":40,"referenced_works":["https://openalex.org/W26444755","https://openalex.org/W100637125","https://openalex.org/W160708530","https://openalex.org/W1585339973","https://openalex.org/W1589803113","https://openalex.org/W1972320135","https://openalex.org/W1975678090","https://openalex.org/W1978744911","https://openalex.org/W1981823571","https://openalex.org/W1995866887","https://openalex.org/W2009193195","https://openalex.org/W2010449588","https://openalex.org/W2017037048","https://openalex.org/W2019547077","https://openalex.org/W2025504409","https://openalex.org/W2034615264","https://openalex.org/W2039524707","https://openalex.org/W2041323061","https://openalex.org/W2044044639","https://openalex.org/W2049769020","https://openalex.org/W2055127611","https://openalex.org/W2060000356","https://openalex.org/W2063387324","https://openalex.org/W2065986052","https://openalex.org/W2076355190","https://openalex.org/W2089923608","https://openalex.org/W2094518494","https://openalex.org/W2108641490","https://openalex.org/W2109282606","https://openalex.org/W2115585096","https://openalex.org/W2117309555","https://openalex.org/W2118399034","https://openalex.org/W2124099961","https://openalex.org/W2129696399","https://openalex.org/W2131177331","https://openalex.org/W2131876585","https://openalex.org/W2131933658","https://openalex.org/W2171678141","https://openalex.org/W2315318035","https://openalex.org/W4211254511"],"related_works":["https://openalex.org/W3135757968","https://openalex.org/W3092863788","https://openalex.org/W1980264273","https://openalex.org/W6964536255","https://openalex.org/W1943892181","https://openalex.org/W7220845539","https://openalex.org/W2567369985","https://openalex.org/W70149229","https://openalex.org/W2161917975","https://openalex.org/W2103662968"],"abstract_inverted_index":{"In":[0,115],"this":[1],"review":[2],"are":[3],"described":[4],"the":[5,18,86,102,105,144],"preclinical":[6],"and":[7,34,96],"clinical":[8,54,120],"pharmacological":[9],"data":[10,118],"as":[11,13,46,72],"well":[12],"new":[14],"therapeutic":[15],"indications":[16],"for":[17,53,75,104],"use":[19],"of":[20,56,107,143],"4-aminopyridine.":[21],"4-aminopyridine":[22,57,84,92],"is":[23,39,99],"a":[24,31,40,47],"potassium":[25],"(K+)":[26],"channel":[27],"blocker":[28],"that":[29,66,123],"has":[30],"long":[32],"history":[33],"various":[35],"application":[36,55],"areas.":[37],"It":[38],"chemical":[41],"agent":[42,74],"developed":[43],"in":[44,59,61,65,97,101,110,136],"1963":[45],"bird":[48],"poison.":[49],"The":[50,78],"first":[51],"approval":[52],"was":[58,93],"70\u2019s":[60],"Bulgaria,":[62],"since":[63],"anesthetists":[64],"country":[67],"have":[68],"confirmed":[69],"its":[70],"effect":[71],"reversal":[73],"nondepolarizing":[76],"myorelaxants.":[77],"Bulgarian":[79],"pharmaceutical":[80],"company":[81],"Sopharma":[82],"commersialized":[83],"under":[85],"trade":[87],"name":[88],"Pymadin.":[89],"Since":[90],"then":[91],"extensively":[94],"studied":[95],"2010":[98],"approved":[100],"USA":[103],"treatment":[106],"walking":[108],"disabilities":[109],"patients":[111],"with":[112,141],"multiple":[113],"sclerosis.":[114],"recent":[116],"years,":[117],"from":[119],"trials":[121],"indicated":[122],"K-channel":[124],"blockade":[125],"may":[126],"prove":[127],"to":[128,133],"be":[129],"an":[130],"appropriate":[131],"strategy":[132],"overcome":[134],"disturbances":[135],"nerve":[137],"impulses":[138],"conduction":[139],"associated":[140],"demyelination":[142],"central":[145],"nervous":[146],"system.":[147]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2019-07-30T00:00:00"}